1 / 9

Non Invasive Prenatal Testing Market: Consumables, Method

According to the new market research report “Non-Invasive Prenatal Testing Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).

akshayjadhav
Download Presentation

Non Invasive Prenatal Testing Market: Consumables, Method

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MarketsandMarkets Presents Non Invasive Prenatal Testing Market: Consumables, Method https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

  2. The report "Non-Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW) Browse 110 market data tables and 48 figures spread through 150 pages and in-depth TOC on "Non-Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021" https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

  3. Early buyers will receive 10% customization on this report. https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

  4. The global NIPT market is expected to reach USD 2.88 Billion by 2021 from USD 1.35 Billion in 2016, at a CAGR of 16.4% during the forecast period. • The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period. • The NIPT market is segmented based on product, method, application, end user, and region. Based on region, the NIPT market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is further subsegmented into the U.S. and Canada; while Europe is further subsegmented into Germany, France, the U.K. and Rest of Europe (RoE). In 2016, North America dominated the market, followed by Europe. Factors such as high risk of chromosomal disorders with increasing maternal age and rising government investments are driving the growth of the NIPT market in this region. However, Asia is poised to be the fastest-growing region during the forecast period. The major factors driving the growth of this market are improving healthcare infrastructure, growing per capita income, and increasing awareness programs. https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

  5. On the basis of product, the market is classified into consumables and instruments. The consumable segment is further divided into assay kits & reagents and disposables. The instruments segment is divided into ultrasound devices, NGS systems, PCR instruments, microarrays, and other instruments. In 2016, the consumables segment accounted for the largest share of the market. The high growth in this segment is attributed to the repeated requirements of consumables as compared to instruments in NIPT. • Based on method, the market is classified into ultrasound detection, biochemical screening tests, fetal cells in maternal blood tests, and cell-free DNA in maternal plasma tests. In 2016, the ultrasound detection accounted for the largest share of the market. The cell-free DNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period. The increasing demand for cf-DNA based techniques in NIPT testing and rising government initiatives to provide prenatal services are the factors contributing to the growth of this market. https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

  6. Based on application, the market is segmented into Trisomy, microdeletion syndrome, and other applications. Trisomy forms the largest and fastest-growing application segment of the global market. This is attributed to factors such as increasing maternal age and rising incidence of chromosomal abnormalities. • Based on end user, the NIPT market is segmented into diagnostic laboratories and hospitals. In 2016, the diagnostic laboratories segment accounted for the largest share of the market. Growth in this end-user segment can be attributed to the rising incidence of chromosomal abnormalities and initiatives by companies to provide technologically advanced products to diagnostic laboratories. • The market is highly fragmented with several big and emerging players. Key market players include GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China). https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

  7. https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.htmlhttps://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

  8. Contact Us Contact: Mr. Shelly Singh MarketsandMarkets™ INC.630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 Email:sales@marketsandmarkets.com Research Insight: https://www.marketsandmarkets.com/ResearchInsight/non-invasive-prenatal-testing-market.asp Visit Our Website:https://www.marketsandmarkets.com https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

  9. About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

More Related